Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synapticure
AddedFeb 15, 2024
UpdatedJul 3, 2026
Synapticure

Synapticure

Seed

Synapticure: Personalized virtual care for neurodegenerative diseases, enhancing patient support and outcomes.

HQ
Chicago, IL, US
Founded
2021
Accelerator
Y Combinator logoY CombinatorS20
Overview
Compare
Fundraising
Employees
Website

Synapticure was founded with the mission to deliver personalized virtual clinical care for patients with neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and ALS. The company aims to enhance patient support and outcomes by providing a comprehensive approach that includes neurologists, mental health providers, and care navigators. Synapticure's services are designed to be accessible and compassionate, offering support to patients and caregivers through a coordinated care model that integrates multidisciplinary resources and local aid.

Notable affiliated individuals include experts in neurology and mental health who contribute to the company's innovative care model. Synapticure has garnered attention for its unique approach to patient care, which prioritizes continuous support rather than episodic consultations. The company has achieved significant impact by making its services available in all states and accepting most insurance plans, thereby improving access to specialized care for neurodegenerative conditions.

Synapticure - Similar Companies

NeuroPath logo

NeuroPath

neuropath.life

Reviving Mind logo

Reviving Mind

revivingmind.com

Cerebral logo

Cerebral

cerebral.com

Rthm logo

Rthm

rthm.com

PursueCare logo

PursueCare

pursuecare.com

VivorCare logo

VivorCare

vivorcare.com

Synchronous Health logo

Synchronous Health

sync.health

NeuroX1 logo

NeuroX1

neurox1.com

Therify logo

Therify

therify.co

NewTouch Digital logo

NewTouch Digital

Give Virtual Care logo

Give Virtual Care

SonderMind logo

SonderMind

sondermind.com

Actipulse Neuroscience logo

Actipulse Neuroscience

Jeevam Health logo

Jeevam Health

jeevamhealth.com

Craniometrix logo

Craniometrix

craniometrix.com

Synapticure - Quick Facts

Who are Synapticure's competitors?

Companies similar to Synapticure include NeuroPath, Reviving Mind, Cerebral and Rthm.

When was Synapticure founded?

Synapticure was founded in 2021.

Where is Synapticure's headquarters located?

Synapticure's headquarters is located in Chicago, IL, US.

When was Synapticure's last funding round?

Synapticure's most recent funding round was for $7.1M (USD) in January 2023.

How much has Synapticure raised to-date?

As of Jan 9, 2023, Synapticure has raised a total of $13.3M (USD).

How many employees does Synapticure have?

Synapticure has 35 employees as of Apr 16, 2024.

Synapticure - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Virtual Care
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified